This new authorization replaces the previous $1B share repurchase authorization approved in May 2022, of which approximately $590M remained available. Published first on TheFly – the ultimate ...

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence. HealthDay News — The pooled prevalence of chronic painful ...

Operating loss for the quarter was $590m with an operating margin of (46.8%), in stark contrast to an income from operations of $122m and an operating margin of 8.5% during the same period of the ...

The blocked studies were supposed to be published in the United States Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report. HealthDay News — As a bird flu ...

TROY, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal and nutritional product candidates derived ...

BYFortune Editors and Premier, Inc. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy ...

Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 ...

Bird flu appears to be widespread among birds in Massachusetts, state health and environmental officials said Wednesday. The Division of Fisheries and Wildlife (MassWildlife), the Massachusetts ...

While the U.S. already has vaccines against H5 viruses in its Strategic National Stockpile, they are based on older technology. HealthDay News — The U.S. Department of Health and Human Services (HHS) ...